Insights

Introductory Knowledge of Intellectual Property in Life Sciences – The Essential Relationship Between Medicines and Patents

Vol. 7: Wait what? You can squash a patent? – How to Defeat Patents That Block Advances in Life Science Business-

2025.11.30
Last time, we discussed patent litigation. The most powerful counteraction when accused of patent infringement is to “squash the patent” — that is, to invalidate it. If the patent can be invalidated, the rights that … 黒澤伸行

Vol. 6: Sued for Patent Infringement? – Here’s How the Litigation would Unfold –

2025.11.01
Unlike the United States—a country known for its litigious culture – Japan sees relatively few patent lawsuits. However, the situation is somewhat different in the life sciences sector. In May of this year, a high-profile p… 黒澤伸行

Vol. 5: Do they really creep in? – Development schedules of Generics and Biosimilars

2025.09.30
This time, we are going to talk about generic drugs and biosimilars. These days in Japan we don't hear the word "zoro", but up until about 20 years ago, generic drugs were commonly referred to as "zoro." The word “zoro” stems … 黒澤伸行

Vol. 4: What do you mean “patents can be extended”? – Patent Term Extension: A special system for pharma–

2025.09.01
Last time, we discussed how to obtain a patent, following the process from application to obtaining a patent. I touched on the length of a patent term at the end. Do you remember how long a patent term was? The answer is 20… 黒澤伸行

Vol. 3: Shall we talk about how to obtain a patent? – Process flow from patent application to obtaining a patent –

2025.07.31
So far, we’ve explored the medicine classification and patents (Vol. 1), and the reasons why Medicines and Patents are inseparable (Vol. 2). In this volume, the spotlight fa… 黒澤伸行

Vol. 2: Wow! The success rate of drug development is shockingly low!

2025.07.01
In the previous volume, we discussed the types of pharmaceutical medicines and patents, so you will remember that “new drugs” are brand drugs under the category of ethical drugs… 黒澤伸行

Vol. 1: First, let’s talk about medicine classification and patents

2025.05.30
Most people understand that patents are important in the life sciences industry, including pharmaceuticals and biotechnology. However, many might feel that the complexities of patents make them difficult … 黒澤伸行

脂肪肝疾患における標的エクソソーム送達のための3Dバイオプリント肝パッチをテーマにしたウェビナー告知バナー（講師：Ashok Kumar教授、IIT Kanpur）

Webinar Announcement: 3D Bioprinted Hepatic Patch for Targeted Exosome Delivery in Fatty Liver Disease

2025.12.11
Metabolic dysfunction-associated steatotic liver disease (MASLD, formerly NAFLD) is a complex metabolic liver disorder that can progress from fat accumulation to inflammation, fibrosis, and eventually hepatocellular carcino… 黒澤伸行

PCL格子構造内に封入されたMSCを示す蛍光画像。生細胞（緑）がGelMA内部に均一に分布し、細胞が伸展している様子が確認できる。

High-Stiffness 3D Tissue Models Enabled by PCL–GelMA Hybrid Bioprinting

2025.12.08
Designing scaffolds that provide both high mechanical strength and a biologically supportive environment for cell attachme… 黒澤伸行

Banner image for the webinar “Biofabrication of Dynamic Living Systems: The Power of 4D Bioprinting,” hosted by Prof. Kaushik Chatterjee.

4D Bioprinting for Dynamic Living Systems

2025.11.18
This webinar explored the emerging field of 4D bioprinting, a technology that integrates the time dimension into traditional 3D bioprinting to create smart, shape-morphing scaffolds.These dynamic structures r… 黒澤伸行

Vol. 7: Wait what? You can squash a patent? – How to Defeat Patents That Block Advances in Life Science Business-

Vol. 6: Sued for Patent Infringement? – Here’s How the Litigation would Unfold –

Vol. 5: Do they really creep in? – Development schedules of Generics and Biosimilars

Vol. 4: What do you mean “patents can be extended”? – Patent Term Extension: A special system for pharma–

Vol. 3: Shall we talk about how to obtain a patent? – Process flow from patent application to obtaining a patent –

Vol. 2: Wow! The success rate of drug development is shockingly low!

Vol. 1: First, let’s talk about medicine classification and patents

Webinar Announcement: 3D Bioprinted Hepatic Patch for Targeted Exosome Delivery in Fatty Liver Disease

High-Stiffness 3D Tissue Models Enabled by PCL–GelMA Hybrid Bioprinting

4D Bioprinting for Dynamic Living Systems

Popular articles/人気記事

Recent Posts/最近の投稿

Event Schedule

Insights

Vol. 7: Wait what? You can squash a patent? – How to Defeat Patents That Block Advances in Life Science Business-

Vol. 6: Sued for Patent Infringement? – Here’s How the Litigation would Unfold –

Vol. 5: Do they really creep in? – Development schedules of Generics and Biosimilars

Vol. 4: What do you mean “patents can be extended”? – Patent Term Extension: A special system for pharma–

Vol. 3: Shall we talk about how to obtain a patent? – Process flow from patent application to obtaining a patent –

Vol. 2: Wow! The success rate of drug development is shockingly low!

Vol. 1: First, let’s talk about medicine classification and patents

Webinar Announcement: 3D Bioprinted Hepatic Patch for Targeted Exosome Delivery in Fatty Liver Disease

High-Stiffness 3D Tissue Models Enabled by PCL–GelMA Hybrid Bioprinting

4D Bioprinting for Dynamic Living Systems

Popular articles/人気記事

Recent Posts/最近の投稿

Event Schedule

Tag Cloud